Aziz Sawaf, MBEE, MBA, CFA

Executive Vice President and Chief Financial Officer, Vir Biotechnology, Inc.

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Aziz Sawaf, MBEE, MBA, CFA has been Executive Vice President and Chief Financial Officer of Vir Biotechnology, Inc. since October 5, 2026, according to the company's filing of October 1, 2026.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Vir Biotechnology, Inc. (VIR) Biological Products, (No Diagnostic Substances)	Executive Vice President and Chief Financial Officer	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

October 5, 2026effective
Vir Biotechnology, Inc. appointed Aziz Sawaf, MBEE, MBA, CFA as Executive Vice President and Chief Financial Officer, effective October 5, 2026. Profile of Brent Sabatini, CPA, MBA.
Aziz Sawaf, MBEE, MBA, CFA has been appointed as Executive Vice President and Chief Financial Officer and “principal financial officer” of the Company, effective as of October 5, 2026 (the Effective Date).
[1] Filing by Vir Biotechnology, Inc., filed with the SEC on October 1, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, Vir Biotechnology, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed October 1, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Aziz Sawaf, MBEE, MBA, CFA wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.